M. Burlacu

T2-weighted magnetic resonance imaging characterization of prolactinomas and association with their response to dopamine agonists

D. Maiter, T. Duprez, E. Delgrange, 2018, Endocrine.

Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism.

L. Hegedüs, W. Wiersinga, L. Bartalena, 2018, European journal of endocrinology.

Antithyroid drugs in Graves’ hyperthyroidism: differences between “block and replace” and “titration” regimes in frequency of euthyroidism and Graves’ orbitopathy during treatment

L. Hegedüs, W. Wiersinga, P. Perros, 2020, Journal of Endocrinological Investigation.